Nuclear receptors (NRs) are essential pharmaceutical targets because they’re key regulators of several metabolic and inflammatory diseases, including diabetes, dyslipidemia, cirrhosis, and fibrosis. an focus on their systems of actions and their restorative potentials, aswell as on ways of determine potential sea natural basic products as nuclear receptor modulators. ovarian malignancy, cancer of the colon… Continue reading Nuclear receptors (NRs) are essential pharmaceutical targets because they’re key regulators